IP Library Granted Patent US 9,234,895
Granted Patent B2
US 9,234,895 · App. 13/570,096 · Granted Jan 12, 2016

Methods for identifying and using organ-specific proteins in blood

Inventors: Leroy Hood (Seattle, WA); Biaoyang Lin (Bothell, WA)
Assignee: Institute for Systems Biology
G01N33/68G01N33/6893G06K9/00127
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,234,895
App. No.
13/570,096
Granted
Jan 12, 2016
Kind
B2
Abstract

The present invention relates generally to methods for identifying organ-specific secreted proteins and for identifying organ-specific molecular blood fingerprints therefrom. As such, the present invention provides compositions comprising such proteins, detection reagents for detecting such proteins, and panels, and arrays for determining organ-specific molecular blood fingerprints.

Claims (23)

1. A method for diagnosing a biological condition of an organ in a subject comprising measuring the level of a plurality of organ-specific proteins in the blood of the subject, wherein the plurality of organ-specific proteins comprises at least 10 organ-specific proteins, wherein the organ-specific proteins are secreted from the same organ or specific to the same organ and wherein the levels of the plurality of organ-specific proteins together provide a fingerprint for the biological condition of the organ for diagnosis in the subject.

2. The method of claim 1 wherein a statistically significant altered level in one or more of the organ-specific proteins as compared to a predetermined normal level classifies the subject as having a perturbation from the normal biological state.

3. The method of claim 1 wherein said fingerprint is measured in the blood, serum or plasma of the subject.

4. The method of claim 1 wherein the level of the plurality of organ-specific proteins is measured using a method selected from the group consisting of mass spectrometry, an immunoassay, Western blot, microfluidics/nanotechnology sensors, and aptamer capture assay.

5. The method of claim 4 wherein the level of the plurality of organ-specific proteins is measured using tandem mass spectrometry.

6. The method of claim 4 wherein the level of the plurality of organ-specific proteins is measured using ELISA.

7. The method of claim 1 wherein the plurality of organ-specific proteins comprises about 20 organ-specific proteins.

8. The method of claim 1 wherein the biological condition affects the prostate and wherein the organ-specific proteins are prostate-specific proteins.

9. The method of claim 1 wherein the biological condition affects the breast and wherein the organ-specific proteins are breast-specific proteins.

10. A method for detecting perturbation of a normal biological state of an organ in a subject comprising, (a) contacting a blood sample from the subject with a plurality of detection reagents each specific for an organ-specific protein secreted into blood, wherein the plurality of detection reagents comprises at least 10 detection reagents, wherein each organ-specific protein is secreted from the same organ; (b) measuring the amount of the organ-specific protein detected in the blood sample by each detection reagent; (c) comparing the amount of the organ-specific protein detected in the blood sample by each detection reagent to a predetermined control amount for each respective organ-specific protein; wherein a statistically significant altered level in one or more of the organ-specific proteins indicates a perturbation of the organ in the subject.

11. The method of claim 10 wherein the plurality of detection reagents comprises about 20 detection reagents.

12. The method of claim 10 wherein the perturbation comprises perturbation of the prostate and wherein the organ-specific proteins are prostate-specific proteins.

13. The method of claim 10 wherein the perturbation comprises perturbation of the liver and wherein the organ-specific proteins are liver-specific proteins.

14. The method of claim 10 wherein the perturbation comprises perturbation of the breast and wherein the organ-specific proteins are breast-specific proteins.

15. The method of claim 1 , wherein each organ-specific protein is expressed in the organ at a level at least 1.5 fold as compared to other organs.

16. The method of claim 1 , wherein each organ-specific protein is expressed in the organ at a level at least 2.5 fold as compared to other organs.

17. The method of claim 1 , wherein each organ-specific protein is expressed at a level of at least 3 copies/million in the organ but is expressed at less than 3 copies/million in other organs.

18. The method of claim 10 , wherein each organ-specific protein is expressed in the organ at a level at least 1.5 fold as compared to other organs.

19. The method of claim 10 , wherein each organ-specific protein is expressed in the organ at a level at least 2.5 fold as compared to other organs.

20. The method of claim 10 , wherein each organ-specific protein is expressed at a level of at least 3 copies/million in the organ but is expressed at less than 3 copies/million in other organs.

21. A method for diagnosing a biological condition of an organ in a subject comprising measuring the level of a plurality of organ-specific proteins in the blood of the subject, wherein the plurality of organ-specific proteins comprises at least 10 organ-specific proteins, wherein each organ-specific protein is secreted from the same organ or specific to the same organ, wherein each organ-specific protein is expressed in the organ at a level at least 2.5 fold as compared to other organs, wherein each organ-specific protein is expressed at a level of at least 3 copies/million in the organ but is expressed at less than 3 copies/million in other organs, and wherein the levels of the plurality of organ-specific proteins together provide a fingerprint for the biological condition of the organ for diagnosis in the subject.

22. A method for detecting perturbation of a normal biological state of an organ in a subject comprising, (a) contacting a blood sample from the subject with a plurality of detection reagents each specific for an organ-specific protein secreted into blood, wherein the plurality of detection reagents comprises at least 10 detection reagents, wherein each organ-specific protein is secreted from the same organ, wherein each organ-specific protein is expressed in the organ at a level at least 2.5 fold as compared to other organs, wherein each organ-specific protein is expressed at a level of at least 3 copies/million in the organ but is expressed at less than 3 copies/million in other organs; (b) measuring the amount of the organ-specific protein detected in the blood sample by each detection reagent; (c) comparing the amount of the organ-specific protein detected in the blood sample by each detection reagent to a predetermined control amount for each respective organ-specific protein; wherein a statistically significant altered level in one or more of the organ-specific proteins indicates a perturbation of the organ in the subject.

23. A method for detecting perturbation of a normal biological state of an organ in a subject comprising measuring the level of a plurality of organ-specific proteins in the blood of the subject, wherein the plurality of organ-specific proteins comprises at least 10 organ-specific proteins, wherein each organ-specific protein is secreted from the same organ or specific to the same organ, wherein each organ-specific protein is expressed in the organ at a level at least 2.5 fold as compared to other organs, wherein each organ-specific protein is expressed at a level of at least 3 copies/million in the organ but is expressed at less than 3 copies/million in other organs, and wherein a statistically significant altered level in one or more of the organ-specific proteins as compared to a predetermined normal level classifies the subject as having a perturbation of the organ from the normal biological state.

Assignments (5)
CONFIRMATORY LICENSE Recorded Apr 28, 2026
From: INSTITUTE FOR SYSTEMS BIOLOGY
To: NATIONAL INSTITUTES OF HEALTH
Reel/Frame 075330/0634 →
SECURITY AGREEMENT Recorded Nov 22, 2022
From: BIODESIX, INC.
To: PERCEPTIVE CREDIT HOLDINGS IV, LP
Reel/Frame 061977/0919 →
RELEASE OF SECURITY INTEREST Recorded Aug 12, 2020
From: IND FUNDING LLC
To: INTEGRATED DIAGNOSTICS, INC.
Reel/Frame 053476/0137 →
SECURITY INTEREST IN RIGHTS UNDER A LICENSE AGREEMENT IN WHICH LISTED PATENTS ARE LICENSED Recorded Apr 29, 2014
From: INTEGRATED DIAGNOSTICS, INC.
To: IND FUNDING LLC
Reel/Frame 032785/0261 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 20, 2012
From: HOOD, LEROY; LIN, BIAOYANG
To: INSTITUTE FOR SYSTEMS BIOLOGY
Reel/Frame 028815/0992 →
Continuity (4)
Continuation 11342366 · Jan 27, 2006
Provisional Application 60647685 · Jan 27, 2005
Provisional Application 60683071 · May 20, 2005
Related Publication 20130045873A1 · Feb 21, 2013